Polycyclic aromatic hydrocarbons (PAHs), major toxic components of ambient PM₂.₅, pose a significant threat to children's neurodevelopment due to their ability to cross the placental and immature blood-brain barriers. Epidemiological evidence links PAHs exposure to cognitive impairment (CI), attention-deficit/hyperactivity disorder (ADHD), mood disorder (MD), and autism spectrum disorder (ASD), yet the underlying molecular mechanisms remain poorly understood. Here, we employed an integrative framework combining multi-disease network toxicology, subcellular and neuroanatomical localization, miRNA regulatory network analysis, and molecular docking to systematically investigate PAHs-induced neurodevelopmental toxicity. Our results revealed two tiers of mechanisms: shared effects, in which PAHs disrupted MAPK and PI3K-Akt signaling pathways, impairing neuronal survival, differentiation, and synaptic plasticity across all four disorders; and disease-specific mechanisms, including AKT1/EGFR/SMAD3-mediated CI via medullary cognitive circuit dysfunction, JUN-driven ADHD through cerebellar network disruption, PRKCA/PRKCG and FOS-mediated MD via hippocampal and hypothalamic dysregulation, and HSP90AA1-linked ASD through white matter developmental impairment. Molecular docking confirmed stable interactions between PAHs and these core targets, while miRNA regulators further highlighted post-transcriptional networks. This study proposes a comprehensive "PAHs-target-pathway-disease" framework, suggests potential intervention targets and early biomarkers, and offers mechanistic insights that may support public health strategies aimed at mitigating PAH-related neurodevelopmental risks in children.
Rationale: Traumatic carotid-cavernous sinus fistula (TCCF) is a pathological shunt between the carotid arteries and cavernous sinus due to trauma. Imaging-guided (e.g., ultrasonic image and fluoroscopic roadmap image) direct puncture of the superior ophthalmic vein (SOV) for embolization of TCCF has been previously described in other studies. Patient concerns and diagnosis: We report a case of TCCF in a 58-years-old male patient who was admitted to our hospital with a sustained head injury after falling from a high platform, resulting in rapidly progressive swelling, pain, diminishing vision for more than 6 months, and blindness in his left eye for 1 month. Interventions and outcomes: The patient underwent digital subtraction angiography and endovascular embolization. After the failure of super-selection of the left cavernous sinus, an alternative approach to obliterating the TCCF by puncturing the SOV is directly guided by Dyna-CT. After embolization, the patient’s clinical symptoms gradually disappeared and discharged from the hospital 5 days later. No recurrence or complications occurred during follow-up for 1 year. Conclusion: This case illustrates that direct puncture of the SOV guided by Dyna-CT as an alternative approach to embolization of TCCF is safe, effective, and feasible.
Background: Cognitive impairment is a common feature of neurodegenerative diseases, in which sustained neuroinflammation critically contributes to neuronal dysfunction and memory decline. As a representative condition, Alzheimer’s disease (AD) provides key insights into inflammation‐associated cognitive impairment. However, current anti‐inflammatory interventions exhibit limited efficacy and potential adverse effects, highlighting the need for safer strategies targeting neuroinflammation‐related cognitive dysfunction. Objective: Guided by the concept of food–medicine homology, this study aimed to elucidate the molecular mechanisms by which Ziziphus jujuba alleviates cognitive impairment associated with neuroinflammation. Methods: AD‐relevant targets associated with cognitive dysfunction were obtained from Gene Expression Omnibus (GEO) and GeneCards, and active compounds of Z. jujuba were retrieved from traditional Chinese medicine systems pharmacology (TCMSP). Shared targets were prioritized using least absolute shrinkage and selection operator (LASSO), random forest (RF), and support vector machine (SVM) algorithms. The diagnostic value of the core target was evaluated by receiver operating characteristic (ROC) analysis and a nomogram model with calibration and decision curve analysis (DCA). Functional enrichment, localization analyses, and molecular docking were performed. Experimental validation was conducted in a scopolamine‐induced cognitive impairment mouse model using the Morris water maze (MWM), histopathology, and western blotting. Results: PTGS2 was identified as a key inflammatory target associated with neuroinflammation‐related cognitive impairment and was enriched in the NOD‐like receptor (NLR) signaling pathway. ROC and nomogram analyses indicated good diagnostic and predictive performance (area under the curve [AUC] > 0.7). PTGS2 was localized on chromosome 1 and showed relatively high expression in the cerebral cortex. Z. jujuba compounds exhibited strong binding to PTGS2 (ΔG ≤ −8.0 kcal/mol). In vivo, Z. jujuba improved cognitive performance, alleviated hippocampal injury, and downregulated PTGS2 and related inflammatory signaling pathways, including NLRP3/NF‐κB/MAPK and interleukin (IL)‐1β. Conclusion: This study demonstrates that Z. jujuba ameliorates neuroinflammation‐related cognitive dysfunction primarily by suppressing PTGS2‐centered inflammatory signaling. Integrating computational analyses and in vivo validation in scopolamine‐induced mice, our findings support Z. jujuba as a safe multitarget intervention for inflammation‐associated cognitive impairment and highlight the potential of food–medicine homology in neuroinflammatory cognitive disorders.